Filing Details
- Accession Number:
- 0000059478-25-000216
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-08-12 16:23:06
- Reporting Period:
- 2025-08-12
- Filing Date:
- 2025-08-12
- Accepted Time:
- 2025-08-12 16:23:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 59478 | Eli Lilly & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1538604 | A David Ricks | Lilly Corporate Center Indianapolis IN 46285 | President, Chair, And Ceo | Yes | Yes | No | No |
Transaction Summary
| Purchased: | 1,632 shares | Avg. Price: $644.77 | Total Value: $1,052,263.01 |
| Number of Shares After Transactions: | 546,601 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-08-12 | 1,632 | $644.77 | 546,601 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 54,117 | Indirect | By David A. Ricks 2022 GRAT |
| Common Stock | 300 | Indirect | By Trust |
| Common Stock | 68,656 | Indirect | By David A. Ricks SLAT |
| Common Stock | 7,296 | Indirect | 401(k) |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $644.45 to $645.11, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- Includes 16 shares previously held in a family member's retirement account.
- On May 15, 2025, 5,340 shares of Eli Lilly and Company common stock were transferred to the reporting person as an annuity payment in accordance with the terms of the Grantor Retained Annuity Trust, of which the reporting person is the trustee.
- The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
